Jointown Pharmaceutical Group | Sustainability Performance
Manufactures and distributes pharmaceutical products, including healthcare and chemical solutions, supplying hospitals, clinics, and retail markets.
2000
China
10,001+ employees
Logistics & Supply Chain
$10B+ in revenue
$100M - 500M in profitability
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#1138
Overallⓘ#27
in Chinaⓘ#15
in Logistics & Supply ChainⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Environmental
Carbon emissionsEnergy consumptionWaste ManagementWater ManagementAir & land impactNature and biodiversitySocial
Diversity and InclusionPay GapsExternalitiesGovernance
SDG ImpactFinancial Data
Business performanceCapital & innovationAnalyst projections
Leading
Leading
Aligned
Critical
Intensity
Water consumption intensity (m³ /$M)
Industry Benchmark
62.0
B/M 136.1
Powered by illuminem and GIST Impact
Controversy level
- Jointown Pharmaceutical Group Co Ltd, Chinese major pharma distribution, has faced sustained Chinese NMPA enforcement scrutiny over alleged inadequate cold chain compliance at multiple Chinese pharmacy customer sites, plus the contested 2024 sustained scrutiny over Chinese state-aligned pharmaceutical distribution customer concentration affecting Chinese institutional shareholders.
